Containment of heart failure hospitalizations and cost by angiotensin-converting enzyme inhibitor dosage optimization
- 1 September 2000
- journal article
- clinical trial
- Published by Elsevier in The American Journal of Cardiology
- Vol. 86 (5) , 519-523
- https://doi.org/10.1016/s0002-9149(00)01005-5
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Comparative Effects of Low and High Doses of the Angiotensin-Converting Enzyme Inhibitor, Lisinopril, on Morbidity and Mortality in Chronic Heart FailureCirculation, 1999
- Impact of angiotensin-converting enzyme inhibitor underdosing on rehospitalization rates in congestive heart failureThe American Journal of Cardiology, 1998
- Temporal Patterns in the Medical Treatment of Congestive Heart Failure With Angiotensin-Converting Enzyme Inhibitors in Older Adults, 1989 Through 1995Archives of internal medicine (1960), 1998
- Patterns of angiotensin‐converting enzyme inhibitor prescriptions, educational interventions, and outcomes among hospitalized patients with heart failureClinical Cardiology, 1998
- Quality of Care for Elderly Patients Hospitalized With Heart FailureArchives of internal medicine (1960), 1997
- The treatment of heart failure: The Task Force of the Working Group on Heart Failure of the European Society of CardiologyEuropean Heart Journal, 1997
- Mortality Risk and Patterns of Practice in 4606 Acute Care Patients With Congestive Heart FailureArchives of internal medicine (1960), 1996
- Patterns of angiotensin-converting enzyme inhibitor use in congestive heart failure in two community hospitalsThe American Journal of Cardiology, 1996
- Guidelines for the Evaluation and Management of Heart FailureCirculation, 1995
- Evidence of inadequate investigation and treatment of patients with heart failure.Heart, 1994